Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
The accuracy of noninvasive methods in the prediction of clinically relevant outcomes in patients with chronic liver disease.

Expert review of gastroenterology & hepatology

Fraquelli M, Pozzi R.
PMID: 23237253
Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):679-82. doi: 10.1586/egh.12.55.

The prognosis of chronic liver diseases, which represent a major public health problem, is mainly linked to the extent and progression of liver fibrosis and the subsequent risk of developing cirrhosis and related complications, mainly hepatocellular carcinoma. The article...

Cite
Fraquelli M, Pozzi R. The accuracy of noninvasive methods in the prediction of clinically relevant outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol. 2012;6(6):679-82doi: 10.1586/egh.12.55.
Fraquelli, M., & Pozzi, R. (2012). The accuracy of noninvasive methods in the prediction of clinically relevant outcomes in patients with chronic liver disease. Expert review of gastroenterology & hepatology, 6(6), 679-82. https://doi.org/10.1586/egh.12.55
Fraquelli, Mirella, and Pozzi, Roberta. "The accuracy of noninvasive methods in the prediction of clinically relevant outcomes in patients with chronic liver disease." Expert review of gastroenterology & hepatology vol. 6,6 (2012): 679-82. doi: https://doi.org/10.1586/egh.12.55
Fraquelli M, Pozzi R. The accuracy of noninvasive methods in the prediction of clinically relevant outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):679-82. doi: 10.1586/egh.12.55. PMID: 23237253.
Copy Download .nbib Format: NLM
Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer.

American journal of cancer research

Ricci F, Guffanti F, Affatato R, Brunelli L, Roberta P, Fruscio R, Perego P, Bani MR, Chiorino G, Rinaldi A, Bertoni F, Fratelli M, Damia G.
PMID: 32195028
Am J Cancer Res. 2020 Feb 01;10(2):572-580. eCollection 2020.

Mucinous ovarian carcinoma (mEOC) represents a rare subtype of epithelial ovarian cancer, accounting for 3-4% of all ovarian carcinomas. The rarity of this tumor type renders both the preclinical and clinical research compelling. Very few preclinical

Cite
Ricci F, Guffanti F, Affatato R, et al. Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer. Am J Cancer Res. 2020;10(2):572-580
Ricci, F., Guffanti, F., Affatato, R., Brunelli, L., Roberta, P., Fruscio, R., Perego, P., Bani, M. R., Chiorino, G., Rinaldi, A., Bertoni, F., Fratelli, M., & Damia, G. (2020). Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer. American journal of cancer research, 10(2), 572-580.
Ricci, Francesca, et al. "Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer." American journal of cancer research vol. 10,2 (2020): 572-580.
Ricci F, Guffanti F, Affatato R, Brunelli L, Roberta P, Fruscio R, Perego P, Bani MR, Chiorino G, Rinaldi A, Bertoni F, Fratelli M, Damia G. Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer. Am J Cancer Res. 2020 Feb 01;10(2):572-580. eCollection 2020. PMID: 32195028; PMCID: PMC7061742.
Copy Download .nbib Format: NLM
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.

Human genetics

Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R, Mari F, Renieri A, Furini S.
PMID: 34889978
Hum Genet. 2021 Dec 10; doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10.

The combined impact of common and rare exonic variants in COVID-19 host genetics is currently insufficiently understood. Here, common and rare variants from whole-exome sequencing data of about 4000 SARS-CoV-2-positive individuals were used to define an interpretable machine-learning model...

Cite
Fallerini C, Picchiotti N, Baldassarri M, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2021;doi: 10.1007/s00439-021-02397-7.
Fallerini, C., Picchiotti, N., Baldassarri, M., Zguro, K., Daga, S., Fava, F., Benetti, E., Amitrano, S., Bruttini, M., Palmieri, M., Croci, S., Lista, M., Beligni, G., Valentino, F., Meloni, I., Tanfoni, M., Minnai, F., Colombo, F., Cabri, E., Fratelli, M., Gabbi, C., Mantovani, S., Frullanti, E., Gori, M., Crawley, F. P., Butler-Laporte, G., Richards, B., Zeberg, H., Lipcsey, M., Hultström, M., Ludwig, K. U., Schulte, E. C., Pairo-Castineira, E., Baillie, J. K., Schmidt, A., Frithiof, R., Mari, F., Renieri, A., & Furini, S. (2021). Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Human genetics, . https://doi.org/10.1007/s00439-021-02397-7
Fallerini, Chiara, et al. "Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity." Human genetics vol. (2021). doi: https://doi.org/10.1007/s00439-021-02397-7
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R, Mari F, Renieri A, Furini S. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2021 Dec 10; doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. PMID: 34889978; PMCID: PMC8661833.
Copy Download .nbib Format: NLM
L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease.

Antioxidants (Basel, Switzerland)

Catanesi M, Brandolini L, d'Angelo M, Benedetti E, Tupone MG, Alfonsetti M, Cabri E, Iaconis D, Fratelli M, Cimini A, Castelli V, Allegretti M.
PMID: 34573099
Antioxidants (Basel). 2021 Sep 15;10(9). doi: 10.3390/antiox10091467.

Methionine is an aliphatic, sulfur-containing, essential amino acid that has been demonstrated to have crucial roles in metabolism, innate immunity, and activation of endogenous antioxidant enzymes, including methionine sulfoxide reductase A/B and the biosynthesis of glutathione to counteract oxidative...

Cite
Catanesi M, Brandolini L, d'Angelo M, et al. L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease. Antioxidants (Basel). 2021;10(9)doi: 10.3390/antiox10091467.
Catanesi, M., Brandolini, L., d'Angelo, M., Benedetti, E., Tupone, M. G., Alfonsetti, M., Cabri, E., Iaconis, D., Fratelli, M., Cimini, A., Castelli, V., & Allegretti, M. (2021). L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease. Antioxidants (Basel, Switzerland), 10(9), . https://doi.org/10.3390/antiox10091467
Catanesi, Mariano, et al. "L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease." Antioxidants (Basel, Switzerland) vol. 10,9 (2021). doi: https://doi.org/10.3390/antiox10091467
Catanesi M, Brandolini L, d'Angelo M, Benedetti E, Tupone MG, Alfonsetti M, Cabri E, Iaconis D, Fratelli M, Cimini A, Castelli V, Allegretti M. L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease. Antioxidants (Basel). 2021 Sep 15;10(9). doi: 10.3390/antiox10091467. PMID: 34573099; PMCID: PMC8469212.
Copy Download .nbib Format: NLM
WNT Signaling in Hematological Malignancies.

Frontiers in oncology

Frenquelli M, Tonon G.
PMID: 33409156
Front Oncol. 2020 Dec 21;10:615190. doi: 10.3389/fonc.2020.615190. eCollection 2020.

The role of the WNT signaling pathway in key cellular processes, such as cell proliferation, differentiation and migration is well documented. WNT signaling cascade is initiated by the interaction of WNT ligands with receptors belonging to the Frizzled family,...

Cite
Frenquelli M, Tonon G. WNT Signaling in Hematological Malignancies. Front Oncol. 2020;10:615190doi: 10.3389/fonc.2020.615190.
Frenquelli, M., & Tonon, G. (2020). WNT Signaling in Hematological Malignancies. Frontiers in oncology, 10615190. https://doi.org/10.3389/fonc.2020.615190
Frenquelli, Michela, and Tonon, Giovanni. "WNT Signaling in Hematological Malignancies." Frontiers in oncology vol. 10 (2020): 615190. doi: https://doi.org/10.3389/fonc.2020.615190
Frenquelli M, Tonon G. WNT Signaling in Hematological Malignancies. Front Oncol. 2020 Dec 21;10:615190. doi: 10.3389/fonc.2020.615190. eCollection 2020. PMID: 33409156; PMCID: PMC7779757.
Copy Download .nbib Format: NLM
Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments.

bioRxiv : the preprint server for biology

Tanoli Z, Aldahdooh J, Alam F, Wang Y, Seemab U, Fratelli M, Pavlis P, Hajduch M, Bietrix F, Gribbon P, Zaliani A, Hall MD, Shen M, Brimacombe K, Kulesskiy E, Saarela J, Wennerberg K, Vähä-Koskela M, Tang J.
PMID: 33300000
bioRxiv. 2021 Jun 12; doi: 10.1101/2020.12.03.409409.

Chemosensitivity assays are commonly used for preclinical drug discovery and clinical trial optimization. However, data from independent assays are often discordant, largely attributed to uncharacterized variation in the experimental materials and protocols. We report here the launching of MICHA...

Cite
Tanoli Z, Aldahdooh J, Alam F, et al. Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments. bioRxiv. 2021;doi: 10.1101/2020.12.03.409409.
Tanoli, Z., Aldahdooh, J., Alam, F., Wang, Y., Seemab, U., Fratelli, M., Pavlis, P., Hajduch, M., Bietrix, F., Gribbon, P., Zaliani, A., Hall, M. D., Shen, M., Brimacombe, K., Kulesskiy, E., Saarela, J., Wennerberg, K., Vähä-Koskela, M., & Tang, J. (2021). Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.12.03.409409
Tanoli, Ziaurrehman, et al. "Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2020.12.03.409409
Tanoli Z, Aldahdooh J, Alam F, Wang Y, Seemab U, Fratelli M, Pavlis P, Hajduch M, Bietrix F, Gribbon P, Zaliani A, Hall MD, Shen M, Brimacombe K, Kulesskiy E, Saarela J, Wennerberg K, Vähä-Koskela M, Tang J. Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments. bioRxiv. 2021 Jun 12; doi: 10.1101/2020.12.03.409409. PMID: 33300000; PMCID: PMC7724669.
Copy Download .nbib Format: NLM
Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions.

Pathogens (Basel, Switzerland)

Gallina L, Savini F, Canziani S, Frasnelli M, Lavazza A, Scagliarini A, Lelli D.
PMID: 32709033
Pathogens. 2020 Jul 17;9(7). doi: 10.3390/pathogens9070583.

We describe two cases of skin co-infections with epitheliotropic viruses, detected in two cattle during lumpy skin disease (LSD) surveillance in northern Italy. A diagnostic protocol including different molecular methods as well as negative staining electron microscopy was applied...

Cite
Gallina L, Savini F, Canziani S, et al. Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions. Pathogens. 2020;9(7)doi: 10.3390/pathogens9070583.
Gallina, L., Savini, F., Canziani, S., Frasnelli, M., Lavazza, A., Scagliarini, A., & Lelli, D. (2020). Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions. Pathogens (Basel, Switzerland), 9(7), . https://doi.org/10.3390/pathogens9070583
Gallina, Laura, et al. "Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions." Pathogens (Basel, Switzerland) vol. 9,7 (2020). doi: https://doi.org/10.3390/pathogens9070583
Gallina L, Savini F, Canziani S, Frasnelli M, Lavazza A, Scagliarini A, Lelli D. Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions. Pathogens. 2020 Jul 17;9(7). doi: 10.3390/pathogens9070583. PMID: 32709033; PMCID: PMC7400346.
Copy Download .nbib Format: NLM
Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid.

Journal of experimental & clinical cancer research : CR

Terao M, Goracci L, Celestini V, Kurosaki M, Bolis M, Di Veroli A, Vallerga A, Fratelli M, Lupi M, Corbelli A, Fiordaliso F, Gianni M, Paroni G, Zanetti A, Cruciani G, Garattini E.
PMID: 31847869
J Exp Clin Cancer Res. 2019 Dec 18;38(1):496. doi: 10.1186/s13046-019-1485-4.

In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.

Cite
Terao M, Goracci L, Celestini V, et al. Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. J Exp Clin Cancer Res. 2019;38(1):496doi: 10.1186/s13046-019-1485-4.
Terao, M., Goracci, L., Celestini, V., Kurosaki, M., Bolis, M., Di Veroli, A., Vallerga, A., Fratelli, M., Lupi, M., Corbelli, A., Fiordaliso, F., Gianni, M., Paroni, G., Zanetti, A., Cruciani, G., & Garattini, E. (2019). Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. Journal of experimental & clinical cancer research : CR, 38(1), 496. https://doi.org/10.1186/s13046-019-1485-4
Terao, Mineko, et al. "Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid." Journal of experimental & clinical cancer research : CR vol. 38,1 (2019): 496. doi: https://doi.org/10.1186/s13046-019-1485-4
Terao M, Goracci L, Celestini V, Kurosaki M, Bolis M, Di Veroli A, Vallerga A, Fratelli M, Lupi M, Corbelli A, Fiordaliso F, Gianni M, Paroni G, Zanetti A, Cruciani G, Garattini E. Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. J Exp Clin Cancer Res. 2019 Dec 18;38(1):496. doi: 10.1186/s13046-019-1485-4. PMID: 31847869; PMCID: PMC6918558.
Copy Download .nbib Format: NLM
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.

Human genetics

Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R, Mari F, Renieri A, Furini S.
PMID: 34889978
Hum Genet. 2021 Dec 10; doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10.

The combined impact of common and rare exonic variants in COVID-19 host genetics is currently insufficiently understood. Here, common and rare variants from whole-exome sequencing data of about 4000 SARS-CoV-2-positive individuals were used to define an interpretable machine-learning model...

Cite
Fallerini C, Picchiotti N, Baldassarri M, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2021;doi: 10.1007/s00439-021-02397-7.
Fallerini, C., Picchiotti, N., Baldassarri, M., Zguro, K., Daga, S., Fava, F., Benetti, E., Amitrano, S., Bruttini, M., Palmieri, M., Croci, S., Lista, M., Beligni, G., Valentino, F., Meloni, I., Tanfoni, M., Minnai, F., Colombo, F., Cabri, E., Fratelli, M., Gabbi, C., Mantovani, S., Frullanti, E., Gori, M., Crawley, F. P., Butler-Laporte, G., Richards, B., Zeberg, H., Lipcsey, M., Hultström, M., Ludwig, K. U., Schulte, E. C., Pairo-Castineira, E., Baillie, J. K., Schmidt, A., Frithiof, R., Mari, F., Renieri, A., & Furini, S. (2021). Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Human genetics, . https://doi.org/10.1007/s00439-021-02397-7
Fallerini, Chiara, et al. "Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity." Human genetics vol. (2021). doi: https://doi.org/10.1007/s00439-021-02397-7
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R, Mari F, Renieri A, Furini S. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2021 Dec 10; doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. PMID: 34889978; PMCID: PMC8661833.
Copy Download .nbib Format: NLM
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts.

Therapeutic advances in medical oncology

Ricci F, Brunelli L, Affatato R, Chilà R, Verza M, Indraccolo S, Falcetta F, Fratelli M, Fruscio R, Pastorelli R, Damia G.
PMID: 31258626
Ther Adv Med Oncol. 2019 Jun 24;11:1758835919839543. doi: 10.1177/1758835919839543. eCollection 2019.

BACKGROUND: Epithelial ovarian cancer is the most lethal gynecological cancer and the high mortality is due to the frequent presentation at advanced stage, and to primary or acquired resistance to platinum-based therapy.METHODS: We developed three new models of ovarian...

Cite
Ricci F, Brunelli L, Affatato R, et al. Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts. Ther Adv Med Oncol. 2019;11:1758835919839543doi: 10.1177/1758835919839543.
Ricci, F., Brunelli, L., Affatato, R., Chilà, R., Verza, M., Indraccolo, S., Falcetta, F., Fratelli, M., Fruscio, R., Pastorelli, R., & Damia, G. (2019). Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts. Therapeutic advances in medical oncology, 111758835919839543. https://doi.org/10.1177/1758835919839543
Ricci, Francesca, et al. "Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts." Therapeutic advances in medical oncology vol. 11 (2019): 1758835919839543. doi: https://doi.org/10.1177/1758835919839543
Ricci F, Brunelli L, Affatato R, Chilà R, Verza M, Indraccolo S, Falcetta F, Fratelli M, Fruscio R, Pastorelli R, Damia G. Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts. Ther Adv Med Oncol. 2019 Jun 24;11:1758835919839543. doi: 10.1177/1758835919839543. eCollection 2019. PMID: 31258626; PMCID: PMC6591669.
Copy Download .nbib Format: NLM
A novel classification method for multispectral imaging combined with portable Raman spectroscopy for the analysis of a painting by Vincent Van Gogh.

Applied spectroscopy

Cesaratto A, Nevin A, Valentini G, Brambilla L, Castiglioni C, Toniolo L, Fratelli M, Comelli D.
PMID: 24160874
Appl Spectrosc. 2013 Nov;67(11):1234-41. doi: 10.1366/13-07032.

In this work, a novel combination of portable micro-Raman spectroscopy and semi-automatic methods of data treatment are proposed for the classification and mapping of visible multispectral imaging data for the analysis of a painting on paper by Vincent Van...

Cite
Cesaratto A, Nevin A, Valentini G, et al. A novel classification method for multispectral imaging combined with portable Raman spectroscopy for the analysis of a painting by Vincent Van Gogh. Appl Spectrosc. 2013;67(11):1234-41doi: 10.1366/13-07032.
Cesaratto, A., Nevin, A., Valentini, G., Brambilla, L., Castiglioni, C., Toniolo, L., Fratelli, M., & Comelli, D. (2013). A novel classification method for multispectral imaging combined with portable Raman spectroscopy for the analysis of a painting by Vincent Van Gogh. Applied spectroscopy, 67(11), 1234-41. https://doi.org/10.1366/13-07032
Cesaratto, Anna, et al. "A novel classification method for multispectral imaging combined with portable Raman spectroscopy for the analysis of a painting by Vincent Van Gogh." Applied spectroscopy vol. 67,11 (2013): 1234-41. doi: https://doi.org/10.1366/13-07032
Cesaratto A, Nevin A, Valentini G, Brambilla L, Castiglioni C, Toniolo L, Fratelli M, Comelli D. A novel classification method for multispectral imaging combined with portable Raman spectroscopy for the analysis of a painting by Vincent Van Gogh. Appl Spectrosc. 2013 Nov;67(11):1234-41. doi: 10.1366/13-07032. PMID: 24160874.
Copy Download .nbib Format: NLM
Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Mazza S, Conforti FS, Forzenigo LV, Piazza N, Bertè R, Costantino A, Fraquelli M, Coletta M, Rimola J, Vecchi M, Caprioli F.
PMID: 34116973
Dig Liver Dis. 2022 Jan;54(1):69-75. doi: 10.1016/j.dld.2021.05.018. Epub 2021 Jun 08.

BACKGROUND: the assessment of fibrosis in Crohn's disease (CD) bowel lesions helps to guide therapeutic decisions. Real-time elastography (RTE) and delayed-enhancement magnetic resonance enterography (DE-MRE) have demonstrated good accuracy in quantifying CD-related ileal fibrosis as compared with histological examination....

Cite
Mazza S, Conforti FS, Forzenigo LV, et al. Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease. Dig Liver Dis. 2021;54(1):69-75doi: 10.1016/j.dld.2021.05.018.
Mazza, S., Conforti, F. S., Forzenigo, L. V., Piazza, N., Bertè, R., Costantino, A., Fraquelli, M., Coletta, M., Rimola, J., Vecchi, M., & Caprioli, F. (2022). Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 54(1), 69-75. https://doi.org/10.1016/j.dld.2021.05.018
Mazza, Stefano, et al. "Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 54,1 (2022): 69-75. doi: https://doi.org/10.1016/j.dld.2021.05.018
Mazza S, Conforti FS, Forzenigo LV, Piazza N, Bertè R, Costantino A, Fraquelli M, Coletta M, Rimola J, Vecchi M, Caprioli F. Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease. Dig Liver Dis. 2022 Jan;54(1):69-75. doi: 10.1016/j.dld.2021.05.018. Epub 2021 Jun 08. PMID: 34116973.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries